18-66505261-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021153.4(CDH19):c.1870C>A(p.Gln624Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000419 in 1,433,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021153.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH19 | NM_021153.4 | c.1870C>A | p.Gln624Lys | missense_variant | 12/12 | ENST00000262150.7 | NP_066976.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH19 | ENST00000262150.7 | c.1870C>A | p.Gln624Lys | missense_variant | 12/12 | 1 | NM_021153.4 | ENSP00000262150.2 | ||
CDH19 | ENST00000579658.5 | n.*216C>A | non_coding_transcript_exon_variant | 12/12 | 1 | ENSP00000463085.1 | ||||
CDH19 | ENST00000579658.5 | n.*216C>A | 3_prime_UTR_variant | 12/12 | 1 | ENSP00000463085.1 | ||||
CDH19 | ENST00000540086 | c.*27C>A | 3_prime_UTR_variant | 10/10 | 2 | ENSP00000439593.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000419 AC: 6AN: 1433630Hom.: 0 Cov.: 30 AF XY: 0.00000421 AC XY: 3AN XY: 712760
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2022 | The c.1870C>A (p.Q624K) alteration is located in exon 12 (coding exon 11) of the CDH19 gene. This alteration results from a C to A substitution at nucleotide position 1870, causing the glutamine (Q) at amino acid position 624 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at